AB Biotek positions yeast-based supplement for trained immunity following mRNA vaccine study

04 Feb 2022 --- UK-based AB Biotek has unveiled a yeast-based supplement ABB C1 ImmunoEssentials, which may support the type of immunity induced by certain vaccines.

Researchers concluded the combination of beta-glucans and selenium- and a zinc-enriched postbiotic “appears to stimulate trained immunity in association with influenza and COVID-19 mRNA vaccines.”

“ABB C1 ImmunoEssentials provides consumers with a synergistic combination for trained immunity,” says Gerald Dard, managing director, AB Biotek Human Nutrition and Health.

“To bring to the marketplace a preventive health solution at a time when COVID-19 and other pathogens are exposing the importance of a healthy microbiome is ground-breaking.”

Activating different types of immunity
ABB C1 ImmunoEssentials is a combination of yeast-based ingredients with a beta-1,3/1,6-glucan complex and heat-treated Saccharomyces cerevisiae rich in selenium and zinc.

ABB C1 ImmunoEssentials is positioned as a preventive health solution that supports trained immunity.Combining beta-glucans with selenium and zinc delivered through yeast fermentation, ABB C1 is positioned to “close the gap between innate and adaptive immunity by empowering both.”

It offers a holistic approach by targeting innate immune response, accelerating the natural adaptive immune reaction, and controlling hyperreactivity events such as poor short-term results or longer COVID-19 symptoms.

The product is available in stick packs, capsules, tablets, gummies and bulk powder.

The measured effects
The randomized, double-blind, placebo-controlled study was conducted in 34 volunteers who were vaccinated against influenza (Chiromas) and 38 volunteers vaccinated against COVID-19 (Comirnaty). The day after the vaccine, the participants received either the yeast-based combination or a placebo.

The duration of treatment was 30 and 35 days for the influenza and COVID-19 vaccine groups, respectively. Mean levels of CD4+T cells increased from 910.7 at baseline to 1000.2 cells/µL after the second dose of the COVID-19 vaccine in the ABB C1 group, whereas there was a decrease from 1055.1 to 929.8 cells/µL in the placebo group.

Changes of CD3+T and CD8+T lymphocytes showed a similar trend. In the COVID-19 cohort, the increases in both IgG and IgM were higher in the ABB C1 supplement than in the placebo group.

“We view this product as a new gold standard for this supplement category,” says Carlos de Lecea, global portfolio manager and technical lead, AB Biotek Human Nutrition and Health.

AB Biotek is a global business division of Associated British Foods.

Immunity still contagious
Ingredients to support a healthy immune system are still on-trend as the pandemic presses on.

A recent collaboration between Starbucks and PepsiCo brought Baya energy drink to the market, which combines caffeine from the coffee fruit with vitamin C in a carbonated beverage.

Kirin Beverage also highlighted 2022 will be an important year for immunity-supporting drinks. The Japan-based company revealed part of its strategy this year will focus on instilling an immune care habit in consumers.

Edited by Missy Green

To contact our editorial team please email us at editorial@cnsmedia.com